How could it possibly be double-blind? That would mean they would need to inject a placebo using a fairly invasive procedure. I'm sure the ethics committee would have some difficulties with that. Sirflox was open label and probably a good guide to what FDA would expect.
More likely is Oncosil+gemcitabine vs gemcitabine alone as control. I don't think FDA like historical controls unless absolutely necessary......[which I now see is exactly what rg said!]
- Forums
- ASX - By Stock
- Sales to overseas markets
How could it possibly be double-blind? That would mean they...
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSL (ASX) to my watchlist
|
|||||
Last
1.1¢ |
Change
-0.001(8.33%) |
Mkt cap ! $41.62M |
Open | High | Low | Value | Volume |
1.2¢ | 1.2¢ | 1.0¢ | $24.99K | 2.277M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 1958465 | 1.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.2¢ | 5112465 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 1958465 | 0.011 |
27 | 15321875 | 0.010 |
24 | 14248472 | 0.009 |
10 | 6887500 | 0.008 |
10 | 3839285 | 0.007 |
Price($) | Vol. | No. |
---|---|---|
0.012 | 5112465 | 8 |
0.013 | 11258832 | 8 |
0.014 | 6687166 | 9 |
0.015 | 8500000 | 3 |
0.016 | 4962091 | 4 |
Last trade - 16.10pm 26/08/2024 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |